Nexgenrx Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2016.
2016 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Nexgenrx Pharmaceuticals Private Limited

Nexgenrx Pharmaceuticals Private Limited, a active private limited company, was established on 27 June 2016 in New Delhi, Delhi, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U36994DL2016PTC302167. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.97 Cr and a paid-up capital of ₹1.97 Cr.

It upholds a compliant status. Employing 52 professional, Its leadership includes Mohammad Rashid Hasan (Director), Pankaj Kumar Shrivastwa (Additional Director), Ram Mohan Jha (Additional Director). Past directors included Khushaboo Kumari, Ritesh Srivastava, Sweta Kumari. It holds ₹3.89 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Hindustan Times House,Level 10 K. G Marg Connaught Place, New Delhi, Delhi, 110001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U36994DL2016PTC302167

  • Registration Number

    302167

  • Incorporation Date

    27 June 2016

  • Authorized Capital

    ₹1.97 Cr

  • Paid-Up Capital

    ₹1.97 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.97 Cr
  • Paid Up Capital ₹ 1.97 Cr
  • Company Age 9 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 3.89 Cr
  • Revenue Growth **** 1347.70%
  • Profit Growth **** 117.50%
  • Ebitda **** 345.21%
  • Net Worth 32.44%
  • Total Assets **** 7.92%
Company report

Nexgenrx Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nexgenrx Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nexgenrx Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Mohammad Rashid Hasan Director 27 Jun 2016 Current
Pankaj Kumar Shrivastwa Additional Director 11 Jul 2019 Current
Ram Mohan Jha Additional Director 11 Jul 2019 Current
Ritesh Srivastava Director 07 Jan 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Jul 2019 Past
Pramod Abcsdd Director 28 Jan 2018 Past
Pramod Abcsdd Director 01 Jul 2019 Past
Pramod Abcsdd Director 01 Oct 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nexgenrx Pharmaceuticals.

Nexgenrx Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1347.7% increase. The company also saw a substantial improvement in profitability, with a 117.5% increase in profit. The company's net worth Soared by an impressive increase of 32.44%.

Nexgenrx Pharmaceuticals revenue growth over time
Nexgenrx Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 1347.70%
*******
*******
*******
*******
Revenue from Operations
*******
 1344.45%
*******
*******
*******
*******
Total Assets
*******
 7.92%
*******
*******
*******
*******
Profit or Loss
*******
 117.50%
*******
*******
*******
*******
Net Worth
*******
 32.44%
*******
*******
*******
*******
EBITDA
*******
 345.21%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nexgenrx Pharmaceuticals?

In 2023, Nexgenrx Pharmaceuticals had a public holding of 67.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹38,907,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Sidbi : 3.89 Cr
Latest Charge Details
Date Lender Amount Status
20 Mar 2024 Sidbi ₹1.36 Cr Open
28 Dec 2021 Sidbi ₹5.28 M Open
18 Nov 2020 Sidbi ₹2.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Nexgenrx Pharmaceuticals?

Nexgenrx Pharmaceuticals has a workforce of 52 employees as of Apr 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nexgenrx Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexgenrx Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nexgenrx Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Nexgenrx Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Nexgenrx Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Charges

    Progress on A charge with Sidbi amounted to Rs. 1.36 Cr with Charge ID 100895539 was registered on 20 Mar 2024. was documented.

  • Charges

    A charge with Sidbi amounted to Rs. 0.53 Cr with Charge ID 100515687 was registered on 28 Dec 2021. was recorded as a recent event.

  • Charges

    The activity A charge with Sidbi amounted to Rs. 2.00 Cr with Charge ID 100388722 was registered on 18 Nov 2020. was completed.

  • Director Appointment

    Progress on Pankaj Kumar Shrivastwa was appointed as a Additional Director was appointed as a Additional Director on 11 Jul 2019 & has been associated with this company since 6 years 7 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nexgenrx Pharmaceuticals Private Limited?

The CIN of Nexgenrx Pharmaceuticals Private Limited is U36994DL2016PTC302167.

Where is Nexgenrx Pharmaceuticals Private Limited headquartered?

Nexgenrx Pharmaceuticals Private Limited is headquartered at Hindustan Times House,Level 10 K. G Marg Connaught Place, New Delhi, Delhi, 110001.

When was Nexgenrx Pharmaceuticals Private Limited incorporated?

Nexgenrx Pharmaceuticals Private Limited was incorporated on 27 June 2016.

Who are the current directors of Nexgenrx Pharmaceuticals Private Limited?

The current directors of Nexgenrx Pharmaceuticals Private Limited are

What is the primary industry of Nexgenrx Pharmaceuticals Private Limited?

The primary industry of Nexgenrx Pharmaceuticals Private Limited is Hospital And Medical Care.

Is Nexgenrx Pharmaceuticals Private Limited a listed company?

Nexgenrx Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Nexgenrx Pharmaceuticals Private Limited?

The authorized capital of Nexgenrx Pharmaceuticals Private Limited is ₹1.97 Cr, and the paid-up capital is ₹1.97 Cr.

What is the compliance status of Nexgenrx Pharmaceuticals Private Limited?

The compliance status of Nexgenrx Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available